Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

March 31, 2015

By Kristin J. Kelley

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Ferumoxytol (Feraheme), the intravenous iron-replacement drug indicated for anemic adults with chronic kidney disease, will now carry a boxed warning about …

By Larry Husten

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

An apple a day does not appear to keep the doctor away, but it might keep the pharmacist away, according to a JAMA Internal Medicine study.

Researchers examined the association between healthcare utilization …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

The Canadian Task Force on Preventive Health Care has issued guidelines on obesity prevention and management among children in primary care settings.

Among …

March 30, 2015

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The evidence is insufficient to weigh the benefits and harms of screening for iron-deficiency anemia in asymptomatic children aged 6 to 24 months, according to a draft recommendation statement from the U.S. Preventive Services Task Force.

The statement is in line with …

By The Editors

The Obama Administration has released the National Action Plan for Combating Antibiotic-Resistant Bacteria — "a roadmap to guide the …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Sofosbuvir-based therapy is cost-effective in patients with hepatitis C genotype 2 or 3 infection plus cirrhosis and in those who've previously been treated with interferon, according to a simulation study …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

When prescribing oral, liquid medications for children, only metric-based dosing with milliliters should be used "to avoid confusion and dosing errors associated with common …

March 27, 2015

By Kelly Young

Edited by André Sofair, MD, MPH

The CDC's Advisory Committee on Immunization Practices has published its recommendations for vaccinating against human papillomavirus with the nine-valent HPV vaccine (Gardasil 9) in MMWR.

The nine-valent vaccine targets five more strains than the quadrivalent version, and these five strains (31, 33, 45, 52, and 58) …

Pages